Nephrology in Bangladesh

Rashid, Harun Ur; Alam, Mohammad Rafiqul; Khanam, A; Rahman, Muhibur; Ahmed, Sohel; Mostafi, Mamun; Arefin, Shakib Uz Zaman; Kashem, Tasnuva Sarah; Begum, Nura Afza Salma; Alam, Kazi Shahnoor; Islam, Nazrul

doi:10.1007/978-3-030-56890-0_18

Cited by 6 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, the Kidney Foundation, Bangladesh's Renal Registry, and data sharing with the United States Renal Data System (USRDS) contributed to global advancements. 1 The tale of nephrology in Bangladesh is one of resilience, innovation, and compassion -a tale that continues to unfold, enriching lives, and reaching new heights of excellence with each passing year.…”

Section: History Of Nephrology In Bangladeshmentioning

confidence: 99%

Renal Disease in Bangladesh Perspective

Mostafi,

Jabin

2023

Bangla J Med

View full text Add to dashboard Cite

Bangladesh is one of the most densely populated areas in the world. Renal diseases are increasingly recognized and encompasses a large share of the health sector. About 20 million people are suffering from chronic kidney disease, and of them, approximately 35,000–40,000 develop endstage renal disease each year. Chronic glomerulonephritis, diabetes mellitus and hypertension are the principal causes of chronic kidney disease. Hypovolemia, sepsis, obstetric complications and drugs (including herbal and homeopathic remedies) are common causes of acute kidney injury. All three renal replacement therapy modalities (hemodialysis, peritoneal dialysis and renal transplantation) are performed in Bangladesh, yet only 25% of end-stage renal disease patients have access to treatment due to inadequate facilities and high healthcare costs. Nephrology as a specialty started its journey in 1973 in Bangladesh and now about 300 Nephrologists are managing the subject. Still there is huge need for more Nephrologists, as only one nephrologist is available for about every 0.8 million people. The country has improved financially from low- to low-middleincome country. Health sector is also more improving gradually. The government is now setting up renal care at rural level, introducing screening programs for early detection and prevention of kidney and other noncommunicable diseases. At the same time steps are under way to improve the advanced renal services at secondary and tertiary health institutes. Kidney transplantation started in 1982 and only live related transplantation are being done in several government and private organization. ABO-incompatible kidney transplantation has already been performed. Recently decease renal transplantation has also been performed. Research and training opportunities are expanding in collaboration with international organizations. Renal services appears up to date in this country but needs more and more enhancement to cope up the ever increasing burden. Bangladesh J Medicine 2023; 34(3): 180-185

show abstract

Section: History Of Nephrology In Bangladeshmentioning

confidence: 99%

Renal Disease in Bangladesh Perspective

Mostafi,

Jabin

2023

Bangla J Med

View full text Add to dashboard Cite

show abstract

“…In Bangladesh, kidney transplantations have been conducted since 1982. Unfortunately, only 25% of ESRD patients in Bangladesh can access renal replacement therapy, and, among them, only 2% undergo renal transplantation [ 1 ]. A scarcity of kidney donors has worsened this problem.…”

Section: Introductionmentioning

confidence: 99%

Experiences of performing ABO-incompatible kidney transplantation in Bangladesh

Begum

Kashem

Nobi

et al. 2022

Korean J Transplant

Self Cite

View full text Add to dashboard Cite

Background:The number of end-stage renal disease (ESRD) patients is increasing in Bangladesh. Currently, living kidney donation is the only viable option for transplantation in Bangladesh, and it is further restricted by ABO compatibility issues. We have performed ABO-incompatible kidney transplantations (ABOi KTs) in Bangladesh since 2018. This study examines our experiences with seven cases of ABOi KT. Methods: The desensitization protocol included low-dose rituximab (100 mg/body) followed by plasma exchange (PEX), which was followed by a 5-g dose of intravenous immunoglobulin. Immunosuppression was undertaken using tacrolimus (0.1 mg/kg/day), mycophenolate mofetil (1,500 mg/day), and prednisolone (0.5 mg/kg/day). All patients received basiliximab for induction therapy. Results:The median baseline anti-ABO antibody titer was 1:64 (range, 1:32-1:128).Transplantation was performed at a titer of ≤1:8. Our patients attended three to five PEX sessions before transplantation. Graft survival was 100% in the seven cases over a mean period of 22 months. The mean creatinine level was 204.6±47.4 μmol/L. Two patients were suspected of having developed acute rejection and received intravenous methylprednisolone, resulting in improved kidney function. One patient required posttransplant hemodialysis due to delayed graft function and subsequently improved. Infection was the most common complication experienced by ABOi KT patients. Two patients developed severe cytomegalovirus pneumonia and died with functioning grafts. Conclusions: ABOi KT in Bangladesh will substantially expand the living kidney donor pool and bring hope to a large number of ESRD patients without ABO-compatible donors. However, the high cost and risk of acute rejection and infection remain major concerns.

show abstract

Living Organ Donation for Transplantation in Bangladesh: Reality and Problems

Siraj

2022

HEC Forum

View full text Add to dashboard Cite

Nephrology in Bangladesh

Cited by 6 publications

References 21 publications

Renal Disease in Bangladesh Perspective

Renal Disease in Bangladesh Perspective

Experiences of performing ABO-incompatible kidney transplantation in Bangladesh

Living Organ Donation for Transplantation in Bangladesh: Reality and Problems

Contact Info

Product

Resources

About